COVID-19
NCA009 Covid-19 Collection
Year Started: 2020
The Covid-19 collection consists of blood, serum, saliva, sputum, nasal strips, nasopharyngeal & oropharyngeal swabs and pleural fluid from patients infected with the novel coronavirus. In some cases, longitudinal samples have and will be collected, which could include samples prior to or after infections with Covid-19. The Covid-19 collection aims to promote biomedical research by providing biomaterial to academic and commercial researchers/partners to facilitate high-quality research to answer a range of questions including: • How does Covid-19 make some people severely unwell? • Does our immune system protect us from re-infection with COVID-19 after we have recovered from infection? • How well do tests for Covid-19 work? • What are the best ways to identify or test for Covid-19? • How does the body respond throughout the course of infection, recovery and possible reinfection? • How long does our immune system protects us from re-infection with Covid-19 after we have recovered from infection? • How does the immune system contribute to long-term post viral symptoms? The biological samples collected will enable a number of different analyses to be performed. This may include (but is not limited to): • The effects of long Covid-19 • Biomarker studies • Immunological studies • Multi-morbidity studies • Functional analysis of cells of the respiratory system
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
Associated Data Type | Procurement Timeframe |
---|---|
Clinical records | 0 - 3 months |
Followup records | 0 - 3 months |
Freezer temperature logs | 0 - 3 months |
Imaging data | 0 - 3 months |
Pathology records | 0 - 3 months |
Primary care records | 0 - 3 months |
Survey data | 0 - 3 months |
Treatment records | 0 - 3 months |
Warm ischemic time | 0 - 3 months |
Donor Ethnicity | 0 - 3 months |
Female
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | Not applicable | 100% | ||
Serum | -60°C to -85°C | Not applicable | 100% | ||
Plasma | -60°C to -85°C | Not applicable | 100% | ||
Swab | -60°C to -85°C | Not applicable | 100% | ||
Saliva | -60°C to -85°C | Not applicable | 75% -99% | ||
Pleural fluid PFL | -60°C to -85°C | Not applicable | 75% -99% | ||
Sputum | -60°C to -85°C | Not applicable | 75% -99% | ||
Cerebrospinal fluid | -60°C to -85°C | Not applicable | 11 - 25% |
Male
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Whole blood | -60°C to -85°C | Not applicable | 100% | ||
Serum | -60°C to -85°C | Not applicable | 100% | ||
Plasma | -60°C to -85°C | Not applicable | 100% | ||
Swab | -60°C to -85°C | Not applicable | 100% | ||
Saliva | -60°C to -85°C | Not applicable | 75% -99% | ||
Pleural fluid PFL | -60°C to -85°C | Not applicable | 75% -99% | ||
Sputum | -60°C to -85°C | Not applicable | 75% -99% | ||
Cerebrospinal fluid | -60°C to -85°C | Not applicable | 11 - 25% |